ArticleBMC urology2025
Fluoroscopy-free Moses technology for treating nephrolithiasis accompanied with infundibular stenosis: a prospective safety and efficacy cohort study.
Article in BMC urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUtilization of C-arm and X-ray machines in flexible ureterorenoscopy (f-URS) with Holmium Laser for the treatment of stones exposes both surgeons and patients to potentially harmful radiation. This study investigates the safety and efficacy of our new procedure, X-ray-free retrograde intrarenal surgery (RIRS), for treating nephrolithiasis associated with intrarenal infundibular stenosis.
methodsFrom Apr 2023 to Mar 2024, a prospective analysis as conducted on the medical records of 25 patients, comprising 7 women (28%) and 18 men (72%). Postoperative follow-up at 3 and 6 months revealed stone-free rates of 76% and 84%, respectively.Univariate logistic regression was applied to further analyze the independent risk factor of the successful rate of stones accompanied with intrarenal stenoses.
resultsAccording to the definition established in this study identifying and incising the narrow calyx neck and removing the stone completely without fluoroscopic guidance, the success rate reached 72.0% (18/25). There was a statistical difference in success rates between the lower calyx calculus treatment group (4) and the upper/middle calyx calculus treatment group (14) (P = 0.004). There was no significant statistical difference in success rates between anterior stenosis with calculus treatment (9) and posterior stenosis with calculus treatment (9) (P = 0.748). The location of calculus have a significant impact on the surgical success rate (P = 0.013).
conclusionsFlexible ureterorenoscopy (f-URS) using calyx neck incision and Moses mode holmium laser lithotripsy appears to be a safe and effective technique. With a success rate comparable to that of the traditional X-ray-guided balloon dilation technique, RIRS is particularly suitable for patients with kidney stones located at the upper and middle poles of the kidney, while it can also be considered for patients with stones in the lower calyx. Application to lower calyx stones should be cautiously considered due to anatomical challenges and relatively lower success rates observed.
trial registrationThe trial was registered prior to patient enrollment at the Chinese Clinical Trial Registry (ChiCTR2300070059), date of registration: March 31st, 2023.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.